Africa free of New HIV Infections

AfNHi is an Africa based network of HIV Prevention Research advocates whose vision is an Africa Free of New HIV Infections hence the name AfNHi.  The network began after extended conversations on the need to champion Africans led advocacy in biomedical HIV Prevention Research among partners. AfNHi is seeking to influence and fast-track the biomedical HIV Prevention Research agenda on the continent through local ownership and use of indigenous strategies to enhance Africa’s contribution to the global goals. The network will not only advocate for use of the tools available for preventing new HIV infections but also advocate for the development of New Tools and Technology (NTP)

  • 2012
  • 2013
  • 2015
  • 2017
  • 2018
  • 2012

    WACI health, Civil Society Platform on Health (CiSPHA) and the New HIV Vaccine and Microbicides Advocacy Society (NHVMAS) convened a meeting on HIV prevention research where the idea of an African led HIV prevention research network was born

  • 2013

    Further discussions about the African led HIV prevention research network were cemented during the first Biomedical HIV prevention Forum (BHPF) – ICASA Abuja Nigeria

  • 2015

    AVAC Partners’ Meeting became the impetus to formalize the structure. WACI Health was mandated as secretariat. A steering committee selected from Ghana, Kenya, Malawi, Namibia, Nigeria, South Africa and Uganda

  • 2017

    Name Africa Free of New HIV Infections (AfNHi) adopted by the steering committee. AfNHi official launch – 3rd December at the Biomedical HIV Prevention Forum (BHPF) held as a pre-conference of the ICASA conference, Abidjan Cote d’Ivoire

  • 2018

    Three year (2018 – 2020) AfNHi strategy and website developed.

  • Humanity (Ubuntu): In all programming aspects, AfNHi holds a view of Africa for Africa towards local empowerment for sustainable HIV Prevention Research advocacy

    Equity: Adhere to practice of fairness in resource allocation for realization of justice in what we do

    Accountability: Strive to account for resources and results within our reach

    Partnership: Promote partnerships, synergy, meaningful community engagement and leverage of resources through beneficial and strategic linkages from within and without the organization and utilizing the skills and expertise of all our constituencies.

  • Africa Free of New HIV Infections

    Facilitate and coordinate African led advocacy for HIV Prevention Research towards ending the HIV epidemic in Africa.

  • Facilitate and coordinate African led advocacy for HIV Prevention Research towards ending the HIV epidemic in Africa.
  • Email:

    Twitter: @AfNHi_Tweets

    Facebook: afnhi



Africa has less than 20% of the global population and is home to approximately 70% of people living with HIV (PLWH). The landscape of HIV response has changed over the years with the development of rapid response and user-friendly HIV test kits, affordable and effective antiretroviral drugs, and impactful prevention tools such as voluntary medical male circumcision and oral pre-exposure prophylaxis (PrEP). More still needs to be done to end the AIDS epidemic by addressing challenges in financing, tools and their accessibility to those who need them, community knowledge through increased number of advocates at the local and regional level in HIV Prevention Research Advocacy.

The 2018-2020 strategy developed from concerted efforts of advocates working on HIV Prevention Research in Africa. The strategy provides a collaboration platform for individual advocates, Civil Society Networks, coalitions and institutions working in Africa on HIV Prevention Research Advocacy.

  1. To build a sustainable network of advocates for HIV Prevention Research
  2. Advocate for increased domestic resources for HIV Prevention Research and accountable utilization
  3. Advocate for policies that promote ethical development and delivery of HIV prevention products
  4. Enhance youth engagement on HIV Prevention Research advocacy
  5. Advocate for equitable access to HIV prevention products (Microbicides, Condoms, PrEP, PEP among others)

We believe that right changes in technical resources, advocacy roadmaps and financing strategies will result in program outputs that results in large scale outcomes. Building a strong and vibrant network will strengthen local CSOs’ capacity which will in turn lead to locally owned and driven agendas on HIV Prevention Research. Local visibility and participation pushes and feeds into national and regional agenda. This will consequently result in the needed long term investment in HIV Prevention Research that can help eliminate new HIV infections and end the AIDS epidemic.

  • Implement mechanisms that will significantly increase public health investments fulfilling the commitment to invest at least 5% of GDP to health.
  • Finance health research and innovation in line with the commitment to invest at least 2% of national health budgets to health research and development.
  • Ensure increased efficiencies and effectiveness of available resources for health.
  • Ethical and meaningful community engagement in clinical trials

Constructive engagement with stakeholders to ensure an Africa Free of New HIV infections.

We recognize the technical support and financial resources provided by AVAC in the development process of this strategy through the Coalition to Accelerate and Support Prevention Research (CASPR)








Follow Us On Twitter

Find Us On Facebook

Get In Touch

Nairobi, Kenya
Tel: +254 711 308 858

Cape Town, South Africa
Tel: +27 (71) 4939690

Addis Ababa, Ethiopia
Tel: +251 911 686 246